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Abstract
Background: Health-related quality of life (HRQL) is a relevant outcome measures in intensive care unit (ICU). The
aim of this study was to evaluate HRQL of ICU patients 3 months after discharge using the Arabic version for
Morocco of the EuroQol-5-Dimension (EQ-5D), and to examine the psychometric properties of the questionnaire.
Results: The Arabic version for Morocco of the EQ-5D was approved by the EuroQol group. A prospective cohort
study was conducted after medical ICU discharge. At 3-month follow up, the EQ-5D (self classifier and EQ-VAS) was
administered in consultation or by telephone. EQ-VAS varies from 0 (better HRQL) to 100 (worst HRQL). An
unweighted scoring for EQ5D-index was calculated. EQ5D-index ranges from -0.59 to 1. Test-retest reliability of the
EQ-5D was tested using Kappa coefficient and intraclass correlation coefficient (ICC). Criterion validity was assessed
by correlating EQ-VAS and EQ5D-index with the Short Form 36 (SF-36). Construct validity was tested using simple
and multiple liner regression to assess factors influencing patients’HRQL. 145 survivors answered the EQ-5D. Median
EQ5D-index was 0.52 [0.20-1]. Mean EQ-VAS was 62 ± 20. Test-retest reliability was conducted in 83 patients. ICCs
of EQ5D-index and EQ-VAS were 0.95 and 0.92 respectively. For EQ-5D self classifier, agreement by kappa was
above 0.40. Significant correlations were noted between EQ5D-index, EQ-VAS and SF-36 (p < 0.001). In multivariate
analysis, factors associated with poorer HRQL for EQ5D-index were longer ICU length of stay (b = -0.01; p = 0.017)
and higher educational level (b = -0.2; p = 0.001). For EQ-VAS men were associated with better HRQL (b = 6.5; p =
0.048).
Conclusions: The Arabic version for Morocco of the EQ-5D is reliable and valid. Women, high educational level
and longer ICU length of stay were associated with poorer HRQL.
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Background
Assessing outcome after intensive care unit (ICU) care is
notoriously difficult [1]. Objective study end points such
as mortality are relatively easy to assess. Nevertheless,
these may not be the only outcomes of interest to
patients, families, and healthcare providers. If ICU treat-
ment leads to deterioration in the quality of life, patients
may be concerned that small gains in life expectancy
come at too high a cost. Other outcome measures such
as health-related quality of life (HRQL) are then impera-
tive to medical evaluation [2]. HRQL is actually one of
the most relevant outcome measures for patients,
families, physicians and society [3].
Several scales have been used to measure the different
domains of HRQL; some are generic while others are
disease-specific. The generic scales attempt to capture
aspects of health that are important to all patients and
therefore present the advantage of comparing different
groups of patients [1-4]. The EuroQol -5 Dimensions
(EQ-5D) is a generic questionnaire that has been devel-
oped by an international task force aiming at creating a
simple generic measure that aggregated HRQoL into a
* Correspondence: abouqal@invivo.edu
1Faculty of Medicine, Laboratory of Biostatistics Clinical and Epidemiological
Research, Rabat, Morocco
Full list of author information is available at the end of the article
Khoudri et al. BMC Research Notes 2012, 5:56
http://www.biomedcentral.com/1756-0500/5/56
© 2012 Khoudri et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.single index [5]. The EQ-5D has been already used in
numerous studies and in subsets of critically ill patients
[3]. The validity and reliability of the EQ have been
tested in the ICU population, and it has been recom-
mended for use in critical care medicine [6-10].
The EQ-5D is available in many major languages with
cultural adaptations [11-14]. Although HRQL data are
widely available on a number of western countries, few
d a t aa r ea v a i l a b l ei nA r a b i cc o u n t r i e s[ 1 5 ] .I nN o r t h -
African and Arabic countries, few HRQL studies have
been published in ICUs, a Moroccan study have focused
on measuring HRQL after intensive care using the
Short-Form 36 (SF-36) [16]. However, to our knowledge
this is the first validation study of the EQ-5D in North-
African and Arabic ICUs.
This study aimed to evaluate the HRQL of a Moroccan
cohort’ patients alive 3 months after ICU discharge; to
study its determinants and to assess the psychometric
properties of the Arabic version for Morocco of the EQ-5D.
Methods
Study design, setting and subjects
This was a prospective study of Adult patients who were
discharged between November 2004 and August 2005
from a medical ICU of Rabat University Hospital. The
12-bed medical ICU admits approximately 550 patients
annually with an average age of 40 years. Surgery
patients, coronary, neonates and burn patients are treated
in specialized units. Rabat University Hospital is referral
for habitants in Western-North Morocco. The protocol
was approved by the Hospital Ethics Committee, and
informed consent was obtained from all participants.
Inclusion criteria were adult patients (> 18 years old)
with an ICU stay of more than 24 h. Patients who died
during ICU stay were excluded. Patients discharged alive
from ICU were asked to attend a consultation 3 months
later. Survivors were then administered the EQ-5D in
consultation at the 3-month follow up. If patients did not
come to the follow-up consultation, a telephone contact
was established for a follow-up interview. We have cho-
sen to assess HRQL at 3 months because it seems to be
ideal in the detection of only ICU-related morbidity and
permits early psychological intervention if required [1].
In consultation, questionnaires were self-completed by
the patients with a high education level (secondary/
higher) or administrated by the same investigator if the
education level is lower (none/primary). No proxy assess-
ment was allowed. Follow-up interviews were always con-
ducted by the same interviewer in order to ensure the
EQ-5D reliability and minimize missing values.
Data collection
Background variables at admission included patient
demographic data and pre-admission comorbidity
classified using the Charlson Comorbidity Index (CCI)
[17]: among severely ill patients, a CCI score of two or
greater is associated with 1-year survival of less than
20%. Primary diagnosis, severity of disease assessed by
the Acute Physiology and Chronic Health Evaluation II
(APACHE II) [18], Therapeutic Intervention Scoring
System (TISS) scores [19], use of mechanical ventilation
and length of stay in the ICU were also recorded.
EQ-5D, translation and cultural adaptation process
The first part of the EQ-5D called “self-classifier” covers
five dimensions, namely mobility, self-care, usual activ-
ities, pain/discomfort, and anxiety/depression [7,20].
Each of these dimensions has three response options,
“no problems”, “moderate problems”,a n d“extreme pro-
blems”. Therefore, it classifies a respondent’s health sta-
tus into one of 243 (35) health states. Each health state
can be assigned a weighted utility score based on differ-
ent scoring systems. Due to the unavailability of Moroc-
can’s own value set, we adopted an unweighted scoring
rule based solely on answers provided by subjects to the
descriptive system. The values are ranging from -0.59 to
a maximum of 1 [21]. The second part of the EQ-5D
questionnaire is a visual analogue scale (EQ-VAS) [22].
The EQ-VAS is a vertical, graduated (0-100 points) 20
cm ‘thermometer’, with 100 representing ‘best imagin-
able health state’ and 0 representing ‘worst imaginable
health state. The respondent rated her health on the day
of the survey using both the self-classifier system and
the VAS.
T h eA r a b i cv e r s i o no ft h eE Q - 5 Df o rM o r o c c ow a s
adapted from The United Arab Emirates Arabic version
using EuroQol group guidelines and input [7]. An
experienced translation consultant who is a native
speaker of Moroccan Arabic and fluent in English per-
formed forward translation. Then, a discussion was held
with the project manager to produce a first consensus
version of EQ-5D for Morocco. A detailed report on the
review process outlining the suggested changes was sub-
mitted to the EuroQol business management. Emphasis
was given to produce a clear and natural-sounding ver-
sion that is acceptable to respondents in Morocco rather
than a direct word by word translation. The first Moroc-
c a nc o n s e n s u sv e r s i o no ft h eE Q - 5 Dw a st e s t e do nf i v e
respondents irrelevant to healthcare professions. Then, a
report on respondent testing was sent to the EuroQol
Group business management and the Arabic version of
the EQ-5D for Morocco was finalized. The translation
process has taken into account the socio-cultural con-
text and Moroccan day-life. “Usual activities” was chan-
ged to “daily activities”. “Prayer” was added to the
leisure dimension, “walking” was added to the mobility
dimension, and “discomfort” was changed to “not to feel
good physically”. The Arabic version for Morocco of the
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granted by the EQ-5D website (http://www.euroqol.org).
SF-36 health survey
The SF-36 is a multipurpose survey of general health
status consisting of 36 items that measure eight scales
or health concepts: physical functioning, role physical,
bodily pain, general health, vitality, social functioning,
role emotional and mental health. Each scale is scored
from 0 to 100 with a higher score reflecting a better
quality of life [23]. The SF-36 was used as a reference
instrument since its psychometric properties have been
tested; and it was found both valid and reliable in the
I C Us e t t i n g[ 1 , 2 4 ] .T h eA r a b i cv e r s i o no ft h eS F - 3 6h a s
been already validated in Moroccan medical ICU popu-
lation [16].
Measurement properties
The acceptability of the EQ-5D was tested by the propor-
tion of missing or invalid responses. Responses to items
of the EQ-5D self-classifier were considered invalid if
more than one response level was ticked or if a tick was
made in between two response levels. Responses to the
EQ-VAS were considered invalid when marking was
ambiguous (e.g. more than one score marked).
The test-retest reliability refers to the stability of a
score derived from serial administration of a measure by
the same investigator. It was determined by interviewing
83 survivors, randomly selected, on two occasions sepa-
rated by 7.5 ± 1 day. The interval of a week was chosen
in order to maintain health status between the two
administrations. The level of agreement between
responses to EQ-5D self-classifier, EQ-5D index and EQ-
VAS score of the first and second interview was analysed.
Criterion validity was assessed by comparing responses
to the EQ-5D with comparable subscale scores of the
SF-36 obtained at the same time. This type of criterion
validity is called concurrent validity [25]. The SF-36 was
used as a criterion because, compared to the EQ-5D, it
is a much more detailed generic measure, which has
been shown to cover similar areas of HRQOL [26] and
which has been successfully tested and widely used in
ICUs [1,16,24].
Construct validity is defined as the ability of the EQ-
5D to distinguish between groups that theoretically it
should distinguish between. The construct validity was
assessed using known-groups comparison to test for
hypothesized differences with regard to sociodemo-
graphic, clinical, or ICU stay variables.
Statistical analysis
Descriptive statistics were used to characterize the study
sample and their HRQL. Test-retest reliability was
assessed using an Intraclass Correlation Coefficient
( I C C )f o rE Q - V A Sa n dE Q - 5 Di n d e x .A nI C Ca b o v e
0.70 is considered to be acceptable [27]. Additionally,
the degree of agreement for the EQ-5D self-classifier
was evaluated by kappa statistics, which greater than
0.75 indicates excellent agreement, below 0.40 poor, and
between 0.40 and 0.75 fair-to-good [28]. For criterion
validity with respect to the items of the EQ-5D selfclas-
sifier, we analysed whether the response levels of each
item were associated with different comparable SF-36
scores using t test. For the EQ-VAS score and EQ-5D
index, Pearson and Spearman correlation coefficients
with the SF- 36 subscales were respectively calculated.
Factors influencing HRQL were studied in univariate
analysis using simple linear regression model. Variables
with p < 0.20 were then included in a multiple linear
regression model. The level of significance was 0.05. All
statistical analyses were carried out using SPSS version
13.0 (SPSS; Chicago, IL, USA).
Results
During the study period a total of 311 patients were
admitted to the ICU, and 132 were excluded because of
death in ICU (n = 92), discharge within 24 h of admis-
sion (n = 13), or age under 18 years (n = 27). The
remaining 179 patients were discharge alive from ICU.
Four patients died before the 3-month follow up, and 27
were lost to follow up. At follow up, 3 survivors were
excluded (delirious or unable to understand Arabic), 84
(58%) were interviewed in consultation and 61 (42%)
were interviewed by telephone. Thus, 145 survivors
completed the EQ-5D (Figure 1). The sociodemographic
and clinical characteristics of the study patients (n =
145) are shown in Table 1.
In the total sample, responses to the EQ-5D self classi-
fier are summarized in Table 2. The median of EQ-5D
index was 0.52 [0.20-1]. Mean EQ-VAS was 62 ± 20 and
ranged from 20 to 100. There were no missing data or
invalid responses in the EQ-5D self classifier and EQ-VAS.
Concerning the results of test-retest reliability in the
83 survivors, the ICCs of the EQ-5D index and EQ-VAS
at 7.5 ± 1 day interval were 0.95 and 0.92 respectively
exceeding then 0.70. For EQ-5D self classifier, agree-
ment by kappa was excellent in pain/discomfort dimen-
sion and fair-to-good in the other dimensions (Table 3).
Concerning criterion validity, Table 4 shows the mean
scores of SF-36 subscales according to their level of
response to comparable EQ-5D items. For all EQ-5D
items, mean SF-36 scores were ordered appropriately
and were significantly different between the groups; as
patients reporting moderate or extreme problems for
EQ-5D dimensions at follow up generally had lower
mean SF-36 scores than those without such problems.
Significant correlations were also noted between EQ5D-
index, EQ-VAS and SF-36 subscales (Table 4).
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differences in EQ-5D index and EQ-VAS scores were
found between groups of patients (Table 5). Concerning
EQ-5D index, in univariate analysis, factors associated
with poorer HRQL at follow up were elder age (b =
-0.01; p < 0.001), married status (b = -0.3; p < 0.001),
higher educational level (b = -0.2; p = 0.010), and longer
ICU length of stay (b = -0.01; p = 0.049). In multivariate
analysis, longer ICU length of stay and higher educa-
tional level were both associated with poorer HRQL (b
= -0.01; p = 0.017 and b = -0.2; p = 0.001 respectively).
Concerning EQ-VAS, in univariate analysis, factors asso-
ciated with poorer HRQL at follow up were elder age (b
= -0.4; p = 0.001) and married status (b =- 1 3 . 3 ;p <
0.001). In multivariate analysis, men were associated
with better HRQL (b = 6.5; p = 0.048).
Discussion
This paper reports the results of the first North-African
prospective study concerning the HRQL of ICU patients
using the EQ-5D Arabic version. This study provided
evidence that the Arabic version of the EQ-5D for Mor-
occo has a good acceptability reliability and validity.
Thus, it can be considered as a valid measure of Moroc-
can patients’ health status.
Previous studies have found that the HRQL of patients
surviving ICU tends to be significantly poorer than that
of samples of the general population [29,30]. Our results
showed a relatively high level of HRQL among survivors
3 months after ICU discharge (mean EQ-VAS 62 ± 20
and median EQ-5D index 0.52 [0.20-1]). Other reports
using different tools agree with these results [10,16,31].
In our study, moderate to extreme problems in pain/dis-
comfort were reported by 49% of the responders, 47%
and 45% of patients reported moderate to extreme pro-
blems with usual activities and mobility respectively. But
only 21% reported the same level of problems in self-
care. Elsewhere, anxiety/depression was the only dimen-
sion causing moderate to extreme problems in more
than 50% of the patients. These findings are similar to
Patients admitted to ICU 
(n=311) 
Excluded (n=132) 
x Died in ICU (n=92) 
x Age < 18years (n=27) 
x ICU LOS <24h (n=13) 
Patients discharged alive 
(n=179)
Survivors at 3-month follow-up 
consultation (n=87) 
Patients missed at 3-month 
follow-up (n=92) 
Excluded (n=3) 
x Do not speak Arabic (n=2) 
x Delirious (n=1) 
Excluded (n=31) 
x Lost to follow up (n=27) 
x Died within 3 months (n=4) 
Patients interviewed in consultation 
(n=84) 
Patients interviewed by telephone 
(n=61) 
Figure 1 Patients included and excluded from the study.
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after ICU discharge where pain/discomfort and anxiety/
depression were the most frequently reported problems.
Other studies using different tools [29,31] reported also
t h es a m ef i n d i n g si nI C U sw h e r ee m o t i o n a lp r o b l e m s
and anxiety/depression were the most frequent one.
Concerning EQ-5D index, in order to eliminate the pos-
sible influence that social preferences may have on the
score, an unweighted scoring rule was developed based
solely on answers provided by subjects to the descriptive
system [21]. This unweighted scoring strategy was used
in our study because it simply combines the answers
provided by the subjects to each of item of the
questionnaire.
The EQ-5D was well accepted and understood by ICU
patients at follow-up, as shown by the lack of missing
and invalid responses. Furthermore, EQ-5D is known to
b eas i m p l ea n ds h o r tq u e s t i o n n a i r ee a s i l yu n d e r s t o o d
and answered by the patient; these can make it an
instrument of choice in ICU patients [10].
Because comparative studies require instruments in
several languages, cross-cultural adaptation of HRQL
questionnaires should be entertained carefully [32].
Although EQ-5D has been translated into more than
50 different languages including classic Arabic, few
publications have described the process of cross-cul-
tural adaptation and validation in detail and none is
available in the North-African countries [15]. Before
being used in a socio-cultural and specific setting, the
EQ-5D needs to demonstrate satisfactory psychometric
properties because of its brevity and because of infor-
mation for each dimension being derived from only
one item [13]. The EQ-5D demonstrated good test-ret-
est reliability. The ICC was excellent in our study (0.95
and 0.92 for the EQ-5D index and EQ-VAS respec-
tively). Kappa-statistics weres a t i s f a c t o r yi no v e r a l lt h e
five EQ-5D dimensions (0.66-0.92). Several other vali-
dated EQ-5D versions from foreign countries have also
demonstrated good reliability with comparable results
[11,12,14].
T h eS F - 3 6i so n eo ft h em o s tw i d e l yu s e dg e n e r i c
health status measure that can be considered as a “Gold
Standard” in ICU settings [1,24]. Its psychometric prop-
erties have already been proved in a Moroccan medical
ICU [16]. Comparison of EQ-5D response with subscale
scores of SF-36 showed excellent criterion validity, the
EQ-5D index and EQ-VAS correlated well with the
eight SF-36 health domains. So was found in a German
study comparing EQ-5D and SF-36 in cardiac
Table 1 Sociodemographic and clinical characteristics of
study patients (n = 145)
Characteristics
Age, years; mean ± SD 38.2 ± 17
Gender male; n(%) 79 (54)
Marital status; n(%)
Single 75 (52)
Married 70 (48)
Minimum educational level; n(%)
None 54 (37)
Primary 41 (27)
Secondary/higher 50 (36)
ICU length of stay, days; mediane [IQR] 6 [3-10]
CCI, n (%)
0 92 (64)
1 37 (25)
≥2 16 (11)
APACHE II, first 24 hrs; mean ± SD 14.1 ± 6
TISS, first 24 hrs; mean ± SD 20 ± 6
Mechanical ventilation; n(%) 35 (22)
ICU admitting diagnostic categories; n(%)
Sepsis 36 (24)
Intoxication 33 (23)
Neurologic 23 (16)
Respiratory 21 (15)
Metabolic 14 (9)
Cardiovascular 11 (8)
Miscellaneous 7 (5)
ICU, intensive care unit; CCI, Charlson Comorbidity Index; APACHE II, Acute
Physiology and Chronic Health Evaluation II; TISS, Therapeutic Intervention
Scoring System
Table 2 Score distributions of the EQ-5D self classifier in
ICU patients
EQ-5D
dimensions
Responses; n(%)
No
problems
Moderate
problems
Extreme
problems
Mobility 80 (55) 46 (32) 19 (13)
Self-care 115 (79) 20 (14) 10 (7)
Usual activities 77 (53) 40 (28) 28 (19)
Pain/discomfort 74 (51) 43 (30) 28 (19)
Anxiety/
depression
74 (51) 48 (33) 23 (16)
Table 3 Test-retest reliability of EQ-5D
Kappa-statistic ICC
EQ-5D self classifier
Mobility 0.73
Self-care 0.49
Usual activities 0.66
Pain/discomfort 0.92
Anxiety/depression 0.72
EQ-5D index 0.95
EQ-VAS 0.92
ICC, Intraclass correlation coefficient; VAS, visual analogue scale
ICC > 0.70 is considered acceptable. Kappa statistics > 0.75 indicates excellent
agreement, < 0.40 poor, and between 0.40 and 0.75 fair-to-good
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inflammatory bowel disease [33].
The HRQL of ICU patients has been investigated at
various follow-up times. Assessment of HRQL at 90
days may be ideal for the detection of ICU related
sequelae, because more time passes the larger are the
effects of increasing age and possibly new comorbid-
ities on HRQL [34]. The construct validity of the EQ-
5D was confirmed in our study. In multivariate analy-
sis, linear regression model indicated that women had
poorer HRQL (EQ-VAS), a fact that has been already
reported in the literature where women report worse
health than men in ICUs [16]. Surprisingly, we found
that ICU patients with high education levels had
poorer HRQL contrary to what has been reported in
the literature [10]. The differences between these find-
ings and ours can be explained by cultural specificities,
concerning values, perceptions, and expectations
regarding health care [35]. Patients with a high level of
culture and education may be more emotionally and/
or physically demanding; while those with low educa-
tion levels because the lack of culture, their only reli-
gious beliefs make them consider their health status as
God’s will and may express then better HRQL.
Moreover, poorer HRQL related with high education
level can be also explained by the fact that question-
naires were self-completed by this category of patients,
this may have facilitated the fully expression of health
status assessment. ICU patients with less education
level may have been intimidated by the presence of the
investigator while completing questionnaires. Longer
ICU length of stay was also associated with poorer
HRQL, a fact that is common in earlier studies [10,16].
In our study, age was not found to be related to
HRQL. In fact, the impact of age on HRQL is contro-
versial in ICUs: impairment of HRQL with elderly has
been previously reported [10] whereas other studies
showed no influence of age [36].
There are some limitations in the study. First, the EQ-
5D is a self-administered questionnaire, but the problem
of the low literacy in Morocco yielded to a self-adminis-
tration or administration by the same investigator fol-
lowing the level of education of the patients. This may
introduce bias in the results; however no consensus is
available concerning the problem of administrating
questionnaires in low literacy populations [37]. Second,
a large number of the patients were excluded from the
study; this may have introduced bias into the results.
Table 4 Criterion validity of EQ-5D with regard to SF-36 subscales
SF-36 subscales
GH PF RP RE SF BP VT MH
Mobility
No problems 71 ± 15 96 ± 6 100 ± 0 80 ± 40 88 ± 22 89 ± 17 64 ± 9 74 ± 14
Moderate/extreme 46 ± 15 54 ± 27 38 ± 48 44 ± 50 47 ± 32 50 ± 32 48 ± 14 66 ± 17
P < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.011
Self-care
No problems 63 ± 18 85 ± 18 80 ± 39 72 ± 44 79 ± 25 76 ± 28 60 ± 13 72 ± 15
Moderate/extreme 41 ± 14 37 ± 31 23 ± 42 23 ± 42 23 ± 27 44 ± 13 43 ± 13 64 ± 21
P < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 0.031
Usual activities
No problems 72 ± 12 95 ± 6 96 ± 17 84 ± 36 92 ± 14 86 ± 22 65 ± 8 76 ± 11
Moderate/extreme 42 ± 12 52 ± 28 36 ± 48 36 ± 48 39 ± 28 50 ± 32 45 ± 12 63 ± 18
P < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
Pain/discomfort
No problems 68 ± 17 88 ± 20 91 ± 27 75 ± 43 83 ± 30 96 ± 8 62 ± 13 73 ± 17
Moderate/extreme 48 ± 17 61 ± 30 45 ± 50 48 ± 50 51 ± 31 42 ± 23 50 ± 14 67 ± 16
P < 0.001 < 0.001 < 0.001 0.001 < 0.001 < 0.001 < 0.001 0.038
Anxiety/depression
No problems 68 ± 14 83 ± 24 82 ± 38 92 ± 27 86 ± 23 83 ± 25 64 ± 9 82 ± 8
Moderate/extreme 48 ± 19 66 ± 31 53 ± 50 30 ± 46 47 ± 33 54 ± 32 47 ± 13 57 ± 13
P < 0.001 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
EQ-5D index 0.79* 0.82* 0.68* 0.64* 0.87* 0.75* 0.76* 0.53*
EQ-VAS 0.62† 0.53† 0.48† 0.62† 0.70† 0.47† 0.65† 0.42†
* Spearman correlation coefficients (p < 0.001)
† Pearson correlation coefficients (p < 0.001)
SF-36, Short Form 36; GH, General Health; PF, Physical Functioning; RP, Role Physical; RE, Role Emotional; SF, social Functioning; BP, bodily pain; VT, vitality; MH,
Mental Health
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discharge; HRQL may then vary over time.
Conclusions
We conclude that the Morrocan Arabic EQ-5D has
good acceptability and validity in measuring health sta-
tus after intensive care in Morocco. Three months after
ICU discharge, women and survivors with higher educa-
tional level and longer ICU length of stay expressed
poorer HRQL. In our context, the use of the EQ-5D can
be recommended in order to provide a better picture of
the HRQL among ICU patients. These data provide a
basis for further studies of the EQ-5D in Morocco.
Additional material
Additional file 1: The Arabic version for Morocco of the EuroQol-
5Dimension questionnaire.
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